Table 3. Multivariate analyses of several clinicopathological parameters in relation to survival of patients with EOC.
|
Progression-free survival
|
Overall survival
|
|||
|---|---|---|---|---|
| Variable | Relative risk (95% CI) | P-value | Relative risk (95% CI) | P-value |
| FIGO stage | ||||
| I–II | 1 | >0.0001 | 1 | 0.1648 |
| III–IV | 3.861 (1.615–9.231) | 1.879 (0.772–4.574) | ||
| Histological type | ||||
| Serous | 1 | 0.8083 | (—) | |
| Nonserous | 0.930 (0.395–2.065) | (—) | ||
| Residual tumour (cm) | ||||
| >2 cm | 1 | 0.8406 | 1 | 0.1257 |
| ⩽2 cm | 1.081 (0.507–2.305) | 1.905 (0.835–4.347) | ||
| Peritoneal cytology | ||||
| Negative | 1 | 0.3915 | (—) | |
| Positive | 1.391 (0.654–2.960) | (—) | ||
| Twist expression | ||||
| Negative | 1 | >0.0001 | 1 | >0.0001 |
| Positive | 4.436 (2.275–8.652) | 4.489 (2.113–9.537) | ||
EOC= epithelial ovarian carcinoma; FIGO= International Federation of Gynecology and Obstetrics.